Could this ASX 200 share be in for a $1.7 billion boost?

The ASX 200 healthcare stock is reported to be considering selling some high value assets.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) listed Ramsay Health Care Ltd (ASX: RHC) is recovering from the two-year lows its share price hit on 26 September.

That low point came after takeover negotiations with a consortium of financial investors led by KKR failed to reach an agreement.

The ASX 200 healthcare share continued to trade lower over the following days. But the company's share price has rebounded 14% since 28 September. Shares are currently swapping hands for $64.26 apiece.

Some of that lift may be driven by speculation that Ramsay could be planning to sell a goodly portion of its property assets alongside its stake in European hospital operator Ramsay Sante.

A man sits in contemplation on his sofa looking at his phone as though he has just heard some serious or interesting news.

Image source: Getty Images

A possible $1.7 billion boost for this ASX 200 stock

Citing unnamed sources close to Ramsay, The Australian reports that it understands the ASX 200 healthcare stock is weighing up selling 25% of its real estate assets.

Ramsay Sante, which operates 210 facilities – including primary care units, specialist clinics, and hospitals in Denmark, Norway, Sweden, and Italy – may also be in the mix.

Should Ramsay Healthcare opt to sell its $1.7 billion majority stake in Ramsay Sante and property assets, Macquarie analysts believe the company's share price could see a healthy boost, improving the stock's return on invested capital.

According to Macquarie (courtesy of The Australian):

Applying a multiple of 12.5 times earnings before interest, tax, depreciation and amortisation for the Australian business, combined with Ramsay Sante sale proceeds, would provide a valuation of about $72.00, 15 per cent ahead of the current share price.

With some recent gains posted by the ASX 200 healthcare company, a $72.00 valuation represents a 12% premium on the share price at the time of writing.

Ramsay share price snapshot

The Ramsay share price has enjoyed a strong month, up almost 14%. That outpaces the 7% monthly gain posted by the ASX 200.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Five healthcare workers standing together and smiling.
Healthcare Shares

3 ASX 200 healthcare shares to buy amid sector rout

The experts are backing these stocks for price growth.

Read more »

Researchers and doctors with futuristic 3D hologram overlay for body anatomy or DNA in hospital clinic.
Healthcare Shares

Are investors taking a big gamble chasing 4DX shares higher and higher?

Investor interest in this ASX healthcare tech stock is booming.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

Half a man's face from the nose up peers over a table.
Healthcare Shares

If I could buy only 1 ASX 200 share right now, it would be…

This stock looks underpriced and oversold to me.

Read more »

woman testing substance in laboratory dish, csl share price
Healthcare Shares

CSL shares slide again in March — but is a comeback brewing?

Brokers remain upbeat and see upside up to 95% for the biotech stock.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 57% since February, why Telix shares could keep leaping higher in 2026

A leading analyst believes investors are undervaluing Telix shares. But why?

Read more »

A woman has a thoughtful look on her face as she studies a fan of Australian 20 dollar bills she is holding on one hand while he rest her other hand on her chin in thought.
Healthcare Shares

Is it time to get greedy with CSL shares?

This ASX healthcare giant is out of favour, but that may be where opportunity starts.

Read more »

Stressed, unhappy, and tired scientist with a headache working on a computer in a lab.
Healthcare Shares

3 ASX 200 healthcare shares at multi-year lows

Does this present a buying opportunity?

Read more »